Cinkarna Celje Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cinkarna Celje and similar public comparables like Boryszew, Samyang Holdings, Sniezka, H&R Gruppe and more.

Cinkarna Celje Overview

About Cinkarna Celje

Cinkarna Celje is principally engaged in the production and marketing of titanium dioxide pigment. The company has six operating segments; The titanium dioxides segment comprises the sale of titanium dioxide pigment, Zinc processing segment comprises sales of metallurgical products, Paints, varnishes, mastics, and printing inks segment, the Agro programme segment comprises sales of copper fungicides and Humovit, polymers and the Other segment comprises sales of CEGIPS, sulphuric acid, polymers, service activities, holiday accommodation, etc. The company's geographical segments are Slovenia, the European Union, third countries, and the markets of the former Yugoslavia.


Founded

1873

HQ

Slovenia

Employees

718

Sectors

Financials (LTM)

Revenue: $241M
EBITDA: $44M

EV

$252M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cinkarna Celje Financials

Cinkarna Celje reported last 12-month revenue of $241M and EBITDA of $44M.

In the same LTM period, Cinkarna Celje generated $44M in EBITDA and $24M in net income.

Revenue (LTM)


Cinkarna Celje P&L

In the most recent fiscal year, Cinkarna Celje reported revenue of $241M and EBITDA of $44M.

Cinkarna Celje is profitable as of last fiscal year, with gross margin of 35%, EBITDA margin of 18%, and net margin of 10%.

See analyst estimates for Cinkarna Celje
LTMLast FY202320242025202620272028
Revenue$241M$241M$202M$229M$227M
Gross Profit-$84M$57M$85M$84M
Gross Margin-35%28%37%37%
EBITDA$44M$44M$30M$48M$43M
EBITDA Margin18%18%15%21%19%
EBIT Margin12%12%8%13%11%
Net Profit$24M$24M$14M$26M$22M
Net Margin10%10%7%12%10%

Financial data powered by Morningstar, Inc.

Cinkarna Celje Stock Performance

Cinkarna Celje has current market cap of $267M, and enterprise value of $252M.

Market Cap Evolution


Cinkarna Celje's stock price is $34.32.

Cinkarna Celje share price increased by 0.2% in the last 30 days, and decreased by 9.9% in the last year.

Cinkarna Celje has an EPS (earnings per share) of $3.10.

See more trading valuation data for Cinkarna Celje
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$252M$267M-0.0%0.2%-8.8%-9.9%$3.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cinkarna Celje Valuation Multiples

Cinkarna Celje trades at 1.0x EV/Revenue multiple, and 5.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Cinkarna Celje

EV / Revenue (LTM)


Cinkarna Celje Financial Valuation Multiples

As of July 19, 2026, Cinkarna Celje has market cap of $267M and EV of $252M.

Cinkarna Celje has a P/E ratio of 11.1x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.0x1.2x1.1x1.1x
EV/EBITDA5.7x5.7x8.4x5.3x5.9x
EV/EBIT9.0x9.0x15.9x8.4x10.0x
EV/Gross Profit-3.0x4.4x3.0x3.0x
P/E11.1x11.1x18.4x10.1x12.0x
EV/FCF-41.6x27.7x5.3x41.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cinkarna Celje Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cinkarna Celje Margins & Growth Rates

Cinkarna Celje decreased revenue by 2% and EBITDA by 30% in the last fiscal year.

In the most recent fiscal year, Cinkarna Celje reported gross margin of 35%, EBITDA margin of 18%, and net margin of 10%.

See estimated margins and future growth rates for Cinkarna Celje

Cinkarna Celje Margins

Last FY202420252026202720282029
Gross Margin35%37%37%-
EBITDA Margin18%21%19%13%
EBIT Margin12%13%11%6%
Net Margin10%12%10%6%
FCF Margin3%21%3%-

Cinkarna Celje Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(2%)13%(1%)4%
Gross Profit Growth-47%(1%)-
EBITDA Growth(30%)58%(10%)(28%)
EBIT Growth(45%)89%(15%)(40%)
Net Profit Growth(43%)82%(16%)(39%)
FCF Growth-428%(87%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Cinkarna Celje Operational KPIs

Cinkarna Celje's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Cinkarna Celje's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cinkarna Celje's Rule of X is 23% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cinkarna Celje
LTMLast FY202320242025202620272028
Rule of 4017%17%---
Bessemer Rule of X16%23%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.1M---
Opex to Revenue-24%21%24%26%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cinkarna Celje Competitors

Cinkarna Celje competitors include Boryszew, Samyang Holdings, Sniezka, H&R Gruppe, Hudson Technologies, Selena FM, Natac Natural Ingredients, SINOTECH Co, Grupa Azoty Puławy and Aspo.

Most Cinkarna Celje public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Boryszew0.4x-7.6x-
Samyang Holdings0.3x-(11.9x)-
Sniezka1.5x1.5x8.1x7.8x
H&R Gruppe0.2x0.2x3.3x2.9x
Hudson Technologies1.0x1.0x8.2x8.8x
Selena FM0.6x-5.3x-
Natac Natural Ingredients6.7x6.1x18.7x16.4x
SINOTECH Co1.5x1.2x212.1x-

This data is available for Pro users. Sign up to see all Cinkarna Celje competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cinkarna Celje

When was Cinkarna Celje founded?Cinkarna Celje was founded in 1873.
Where is Cinkarna Celje headquartered?Cinkarna Celje is headquartered in Slovenia.
How many employees does Cinkarna Celje have?As of today, Cinkarna Celje has over 718 employees.
Is Cinkarna Celje publicly listed?Yes, Cinkarna Celje is a public company listed on Ljubljana Stock Exchange.
What is the stock symbol of Cinkarna Celje?Cinkarna Celje trades under CICG ticker.
When did Cinkarna Celje go public?Cinkarna Celje went public in 1998.
Who are competitors of Cinkarna Celje?Cinkarna Celje main competitors include Boryszew, Samyang Holdings, Sniezka, H&R Gruppe, Hudson Technologies, Selena FM, Natac Natural Ingredients, SINOTECH Co, Grupa Azoty Puławy, Aspo.
What is the current market cap of Cinkarna Celje?Cinkarna Celje's current market cap is $267M.
What is the current revenue of Cinkarna Celje?Cinkarna Celje's last 12 months revenue is $241M.
What is the current revenue growth of Cinkarna Celje?Cinkarna Celje revenue growth (NTM/LTM) is (1%).
What is the current EV/Revenue multiple of Cinkarna Celje?Current revenue multiple of Cinkarna Celje is 1.0x.
What is the current EBITDA of Cinkarna Celje?Cinkarna Celje's last 12 months EBITDA is $44M.
What is Cinkarna Celje's EBITDA margin?Cinkarna Celje's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Cinkarna Celje?Current EBITDA multiple of Cinkarna Celje is 5.7x.
How many companies Cinkarna Celje has acquired to date?Cinkarna Celje hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cinkarna Celje has invested to date?Cinkarna Celje hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cinkarna Celje

Lists including Cinkarna Celje

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial